Research is being conducted on the efficacy and safety of treatments for severe asthma, including dupilumab and tezepelumab. The studies involve adults with severe, corticosteroid-dependent asthma, examining the reduction of oral corticosteroid use and the potential for discontinuation. The focus of the research also extends to other areas, such as precision medicine and treatment options for pediatric severe asthma.